Annual report [Section 13 and 15(d), not S-K Item 405]

Business Combination - Intangible Assets Acquired (Details)

v3.25.1
Business Combination - Intangible Assets Acquired (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2024
Indefinite-Lived Intangible Assets [Roll Forward]    
Impairment   $ 0
Goodwill [Roll Forward]    
Impairment of goodwill   0
Carrying Value $ 11,812,476 11,812,476
Pharmagesic    
Indefinite-Lived Intangible Assets [Roll Forward]    
Combination Date Fair Value 69,500,000  
Translation Adjutment (3,789,473)  
Carrying Value 65,710,527 65,710,527
Goodwill [Roll Forward]    
Combination Date Fair Value 12,493,727  
Translation Adjustment (681,291)  
Carrying Value 11,812,436 11,812,436
Pharmagesic | Halneuron for Cancer Related Pain    
Indefinite-Lived Intangible Assets [Roll Forward]    
Combination Date Fair Value 59,900,000  
Translation Adjutment (3,266,035)  
Carrying Value 56,633,965 56,633,965
Pharmagesic | Halneuron for Chemotherapy Induced Neuropathic Pain    
Indefinite-Lived Intangible Assets [Roll Forward]    
Combination Date Fair Value 9,600,000  
Translation Adjutment (523,438)  
Carrying Value $ 9,076,562 $ 9,076,562